Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Crinetics
Biotech
Crinetics pads case for oral hormone disorder drug
Crinetics' oral med regulated levels of a hormone associated with acromegaly in a phase 3 test, setting up a regulatory submission in the second half.
Annalee Armstrong
Mar 19, 2024 9:30am
Crinetics growth disorder drug sees ph. 2 carcinoid syndrome win
Mar 13, 2024 9:16am
Crinetics soars as oral rare disease drug meets standard of care
Sep 11, 2023 7:16am
Crinetics blindsided by nonclinical data that sink orphan drug
Aug 8, 2023 9:30am
FDA ends 14-month hold on one trial as it pauses another
Nov 28, 2022 10:40am